Street vendors wear thick clothes in Heihe, Heilongjiang province, July 25, 2017. The temperature dropped to 12 C on Wednesday morning.[Photo/VCG] While people have sweltered in eastern China over the past two weeks, inhabitants of northeastern areas were putting on thicker clothes this week. Since Monday, cool air has covered most of Heilongjiang province. In the border city of Heihe, the temperature dropped to 12 C early on Monday. In the outdoor markets, peddlers appeared in cotton-padded clothes to guard against the cold. This morning, when I came out to buy food for my family, I wondered whether winter had come early, and I hurried home to get a thick sweater, said Yang Wenbo, 35. In the market, I found lots of tourists, including several Russians, lining up to buy long-sleeved T-shirts or jackets. The cool city has welcomed many visitors trying to escape the heat in other parts of the country. This is my first time in Heihe. Before coming, I couldn't imagine it would be so cool here during the hottest time of summer. The climate is comfortable, Lang Tongxu, 28, a tourist from Shanghai, said on Wednesday. Shanghai has experienced oppressive heat for the past 15 days, and a record high of 40.9 C was set on Sunday. I feel so lucky to be here, and I plan to recommend the city to my friends in Shanghai, Lang said. According to the National Meteorological Center, showers will move from west to east across Heilongjiang, with the temperature falling slightly over the next couple of days. charity braceletscustom rubber wristbandstrio spinners24 hour wristbands coupon codesilicone rubber bandsflash drive wristband
China will expedite approval procedures by one to two years for drugs developed overseas that are in urgent demand domestically, an official with the country's top drug regulator said on Friday.The National Drug Administration of China will speed up approvals for drugs proved effective in fighting rare diseases as well as anticancer and anti-AIDS drugs, said Jiao Hong, head of the administration.Jiao told a news briefing hosted by the State Council Information Office that of the 415 new drugs approved for sale in developed countries over the past 10 years, 76 have been approved for sale in China. Another 201 drugs are undergoing clinical trials in China.In order to fast-track approval procedures, the drug regulator will accept clinical data collected overseas for drugs approved for sale overseas for some life-threatening diseases that are without effective cure, or for rare diseases, she said. There must also be research that proves there is no racial or ethnic difference in response to such drugs.For drugs that require clinical trials in China, the authority will refine testing procedures to cut the time required before approval, she said.The authority has also canceled the requirement for inspection of imported drugs at customs, which would enable the drugs to be shipped directly to pharmacies after customs clearance. The authority would instead step up spot checks.Wang Lifeng, head of the department for product registration for drugs and cosmetics at the administration, said the authority would also enforce a period of data protection for drugs that are developed overseas.No new drugs of the same category would be approved during the protection period, he said, adding that other measures will also be adopted to protect intellectual property rights.Jiao said the administration will develop a professional group of inspectors to conduct spot checks during the research, development and production procedures of drugs.It will also closely monitor cases of adverse reactions for drugs, and suspend their sales or trials, she added.China is the second-largest market for pharmaceutical products, with a total value of $55.9 billion in 2017, up by 16.3 percent year-on-year, according to the China Chamber of Commerce for Import and Export of Medicines and Health Products.?
